Studies on the pathogenesis of hydralazine-induced lupus erythematosus-like syndrome
Yamauchi, Y.
Ryumachi 19(2): 88-104
1979
ISSN/ISBN: 0300-9157 PMID: 312536 Document Number: 148258
Document emailed within 1 workday
Related Documents
Ohe, A.; Koda, S.; Negoro, N.; Okamura, M.; Amatsu, K.; Kohno, M.; Kanayama, Y.; Inoue, T.; Takeda, T. 1982: A case of hydralazine-induced lupus erythematosus with circulating antibodies to native DNA Osaka City Medical Journal 28(2): 149-151Mitchell, J.A.; Sim, R.B.; Sim, E. 1989: CR1 polymorphism in hydralazine-induced systemic lupus erythematosus: DNA restriction fragment length polymorphism Clinical and Experimental Immunology 78(3): 354-358
Haustein, U.F. 1972: Electron microscopy studies on the viral pathogenesis of lupus erythematosus Dermatologische Monatschrift 158(7): 485-491
Gouet, D.; Marechaud, R.; Aucouturier, P.; Touchard, G.; Sudre, Y.; Preud'homme, J.L. 1986: Atenolol induced systemic lupus erythematosus syndrome Journal of Rheumatology 13(2): 446-447
Witman, G.; Davis, R. 1981: A lupus erythematosus syndrome induced by clonidine hydrochloride Rhode Island Medical Journal 64(3): 147-150
Vandersteen, P.R.; Jordon, R.E. 1974: Dermatitis herpetiformis with discoid lupus erythematosus. Occurrence of sulfone-induced discoid lupus erythematosus Archives of Dermatology 110(1): 95-98
Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Engelsen, J.; Nielsen, S.M.; Thorsen, S. 2006: Serious bleeding in systemic lupus erythematosus complicated by lupus anticoagulant-hypoprothrombinaemia syndrome Ugeskrift for Laeger 168(5): 486-487
De Bandt, M.; Meyer, O.; Grossin, M.; Kahn, M.F. 1993: Lupus mastitis heralding systemic lupus erythematosus with antiphospholipid syndrome Journal of Rheumatology 20(7): 1217-1220
Carbajal, N.; Mintz, G.; Fraga, A.; Orozco, J.H. 1973: Etiology and pathogenesis of systemic lupus erythematosus La Prensa Medica Mexicana 38(7): 234-242
Moriuchi, J.; Ichikawa, Y.; Takaya, M.; Shimizu, H.; Tokunaga, M.; Eguchi, T.; Izumi, M.; Ohta, W.; Katsuoka, Y.; Nakajima, I. 1989: Lupus cystitis and performation of the small bowel in a patient with systemic lupus erythematosus and overlapping syndrome Clinical and Experimental Rheumatology 7(5): 533-536
Hewicker, M.; Kromschröder, E.; Trautwein, G. 1989: The pathogenesis of glomerulonephritis in MRL mice--murine lupus erythematosus Verhandlungen der Deutschen Gesellschaft für Pathologie 73: 129-132
Rubin, R.L.; Tang, F.L.; Lucas, A.H.; Spiegelberg, H.L.; Tan, E.M. 1986: IgG subclasses of anti-tetanus toxoid antibodies in adult and newborn normal subjects and in patients with systemic lupus erythematosus, Sjogren's syndrome, and drug-induced autoimmunity Journal of Immunology 137(8): 2522-2527
Asherson, R.A.; Thompson, R.P.; MacLachlan, N.; Baguley, E.; Hicks, P.; Hughes, G.R. 1989: Budd Chiari syndrome, visceral arterial occlusions, recurrent fetal loss and the "lupus anticoagulant" in systemic lupus erythematosus Journal of Rheumatology 16(2): 219-224
Matul'skaia, L.I.; Klimov, V.I.; Riazantseva, T.A.; Pleskovskaia, G.N. 1986: DNAse Ii from phagocytes in the study of the pathogenesis of systemic lupus erythematosus Voprosy Meditsinskoi Khimii 32(1): 32-34
Merk, H. 1984: Pathogenesis of systemic lupus erythematosus: effect of aromatic amines Zeitschrift für Hautkrankheiten 59(11): 709-710
Shepherd, A.M.; Ludden, T.M.; Haegele, K.D.; Talseth, T.; McNay, J.L. 1979: Pharmacokinetics of hydralazine, apparent hydralazine and hydralazine pyruvic acid hydrazone in humans Research Communications in Chemical Pathology and Pharmacology 26(1): 129-144
Pothinamthong, P.; Janjumratsang, P. 2012: A comparative study in efficacy and safety of 0.1% tacrolimus and 0.05% clobetasol propionate ointment in discoid lupus erythematosus by modified cutaneous lupus erythematosus disease area and severity index Journal of the Medical Association of Thailand 95(7): 933-940
Marzano, A.V.; Tavecchio, S.; Menicanti, C.; Crosti, C. 2014: Drug-induced lupus erythematosus Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 149(3): 301-309
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165